Healthcare Publications DNA sequencing market | Page 2

sequencing instruments are encouraging the pharmaceutical companies to outsource DNA
sequencing services, which is contributing to the growth of the segment.
By mode of technology, the global DNA sequencing market has been segmented into
pyrosequencing, semiconductor sequencing, single-molecule real-time sequencing (SMRT),
sequencing by synthesis, sequencing by ligation (SBL), and others.
By mode of application, the global DNA sequencing market has been segmented into
agriculture and animal research, diagnostics, personalized medicine, biomarker discovery,
drug discovery, and others.
By mode of end-users, the global DNA sequencing market has been segmented into
biotechnology and pharmaceutical companies, research centers and government institutes
and academia, clinics and hospitals, and others.
Industry Updates
February 12, 2019: The advent of a new DNA sequencing technique has allowed scientists
to track genetic disorders in individual cancer cells. A tumor’s life history can be
reconstructed for the first time and also how an error in a cell’s DNA has resulted in
uncontrollable growth of a tumor. The latest technology will enable the doctors to get an
understanding of how specific cancer has evolved, and personalized treatment for every
patient will be made for an effective and successful result.
Browse Full Reports @ https://www.marketresearchfuture.com/reports/dna-sequencing-
market-5774
Regional Insights
Geographically, the DNA sequencing market span across regions namely, Europe, North
America, Asia-Pacific, and the Middle East and Africa.
Considering the global scenario, the North American region is predicted to dominate the
DNA sequencing market and is likely to retain its dominance in the coming years. The
growth is credited to the increasing incidences of cancer among the geriatric population, the
presence of market giants, and developed innovation ecology in this region.
The European region is considered to experience a significant growth rate throughout the
appraisal period owing to the growing incidences of the geriatric population suffering from
cancer, efficient reimbursement policies, and sedentary lifestyles.
The Asia Pacific region is presumed to show high potential in the global market due to
increasing awareness regarding DNA sequencing and its applications. The region is also
predicted to experience a fast growth rate owing to the extensive use of DNA sequencing
technologies and its development.
On the other hand, the Middle East & Africa is likely to occupy the lowest market share
owing to the poor medical facilities and lack of advanced technology in the developing
nations in this region.